Insuman Infusat

Insulin human, the active ingredient in Insuman Infusat, is an insulin presented as a solution for subcutaneous use. It is used to control blood glucose in people with diabetes mellitus type 1 and type 2. GNH USA supplies Insuman Infusat as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Insuman Infusat is an insulin analogue that lowers blood glucose by acting on the insulin pathway. - Diabetes mellitus type 1: provides basal insulin to replace the absent endogenous hormone and maintain glycaemic control. - Diabetes mellitus type 2: used as part of a regimen when oral agents are insufficient to achieve target glucose levels.

Insuman Infusat may be associated with a range of adverse reactions.

Common Side Effects: - Hypoglycaemia: low blood sugar episodes, especially if dosing is mismatched with food intake. - Injection site reactions: redness, swelling, or itching at the injection site. - Lipodystrophy: localized changes in fat tissue with repeated injections. - Weight gain: modest increase due to improved glucose utilization. - Edema: mild fluid retention, particularly in the lower extremities.

Serious or Rare Side Effects: - Severe hypoglycaemia leading to loss of consciousness or seizures. - Allergic reactions: urticaria, angioedema, or anaphylaxis. - Hypersensitivity at the injection site with necrosis. - Persistent hyperglycaemia indicating treatment failure. - Unexplained weight loss despite adequate dosing.

When using Insuman Infusat, consider the following safety measures. - Dose individualisation: titrate based on blood glucose monitoring and clinical response. - Hypoglycaemia risk: educate patients on recognising and treating low blood sugar. - Renal impairment: adjust dose and monitor renal function regularly. - Concomitant medications: review for agents that may potentiate hypoglycaemia. - Pregnancy and lactation: evaluate risk‑benefit ratio with a healthcare professional. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Insuman Infusat can interact with several drug classes.

Major Interactions (Avoid): - Beta‑blockers: may mask hypoglycaemia symptoms and prolong its duration. - MAO‑inhibitors: can potentiate insulin’s glucose‑lowering effect. - Sulfonylureas: combined use increases risk of severe hypoglycaemia.

Moderate Interactions (Monitor Closely): - Thiazide diuretics: may raise blood glucose levels, requiring dose adjustment. - Corticosteroids: can induce hyperglycaemia, necessitating higher insulin doses. - Oral contraceptives: may slightly alter insulin requirements.